Lindbrook Capital, LLC - ETON PHARMACEUTICALS INC ownership

ETON PHARMACEUTICALS INC's ticker is ETON and the CUSIP is 29772L108. A total of 33 filers reported holding ETON PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Lindbrook Capital, LLC ownership history of ETON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$17
+21.4%
40.0%0.00%
Q2 2023$14
-6.7%
40.0%0.00%
Q1 2023$15
+36.4%
40.0%0.00%
Q4 2022$1140.0%0.00%
Q3 2022$040.0%0.00%
Q2 2022$040.0%0.00%
Q1 2022$040.0%0.00%
Q4 2021$040.0%0.00%
Q3 2021$040.0%0.00%
Q2 2021$040.00%
Other shareholders
ETON PHARMACEUTICALS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Opaleye Management Inc. 4,040,000$32,845,0004.29%
AWM Investment Company, Inc. 971,681$7,900,0001.00%
Diametric Capital, LP 51,633$420,0000.33%
Mesirow Financial Investment Management, Inc. 1,046$8,504,0000.03%
Hood River Capital Management LLC 76,397$621,0000.02%
Westside Investment Management, Inc. 83,900$4,743,0000.01%
MML INVESTORS SERVICES, LLC 129,250$1,051,0000.01%
PRELUDE CAPITAL MANAGEMENT, LLC 31,961$260,0000.01%
TWO SIGMA INVESTMENTS, LP 126,490$1,028,0000.00%
SEI INVESTMENTS CO 76,397$621,0000.00%
View complete list of ETON PHARMACEUTICALS INC shareholders